Prevalence, Characteristics, and Outcomes of COVID-19-Associated Acute Myocarditis.
Enrico AmmiratiLaura LupiMatteo PalazziniNicholas S HendrenJustin L GrodinCarlo V CannistraciMatthieu SchmidtGuillaume HekimianGiovanni PerettoThomas BochatonAhmad HayekNicolas PiriouSergio LeonardiStefania GuidaAnnalisa TurcoSimone SalaAitor UribarriCaroline M Van de HeyningMassimo MapelliJeness CampodonicoPatrizia PedrottiMaria Isabel Barrionuevo SánchezAlbert Ariza SoleMarco MariniMaria Vittoria MatassiniMickael Vourc'hAntonio CannataDaniel I BromageDaniele BrigugliaJorge SalamancaPablo Diez-VillanuevaJukka LehtonenFlorent HuangStéphanie RusselFrancesco SorianoFabrizio TurriniManlio CiprianiManuela BramerioMattia Di PasqualeAurelia GrosuMichele SenniDavide FarinaPiergiuseppe AgostoniStefania RizzoMonica De GaspariFrancesca MarzoJason M DuranEric D AdlerCristina GiannattasioCristina BassoTheresa McDonaghMathieu KerneisAlain CombesPaolo Guido CamiciJames A de LemosRiccardo M InciardiPublished in: Circulation (2022)
AM occurrence is estimated between 2.4 and 4.1 out of 1000 patients hospitalized for COVID-19. The majority of AM occurs in the absence of pneumonia and is often complicated by hemodynamic instability. AM is a rare complication in patients hospitalized for COVID-19, with an outcome that differs on the basis of the presence of concomitant pneumonia.